Department of Urology, Seoul National Bundang Hospital, Seongnam, Korea.
BJU Int. 2010 Jun;105(11):1526-30. doi: 10.1111/j.1464-410X.2009.09070.x. Epub 2009 Nov 13.
To investigate the rate of pathologically confirmed unfavourable prostate cancers among Korean men who fulfilled the contemporary Epstein criteria for clinically insignificant prostate cancer.
This was a retrospective study of 131 Korean men who underwent radical prostatectomy (RP) for clinically insignificant prostate cancer as defined by contemporary Epstein criteria. We assessed the percentage of unfavourable prostate cancer (pathological Gleason sum > or = 7 and/or extraprostatic extension [EPE]) among these men and tried to identify useful predictors for such unfavourable tumour profiles using uni- and multivariate analyses.
Among 131 men with clinically insignificant prostate cancer, 40 (30.5%) had pathological Gleason > or = 7 tumours after RP. Of these 40 men, four (3.1%) also had EPE on examination of RP specimen. All those who did not have Gleason score upgrading after RP had organ-confined disease from examination of RP specimen. Overall, 40 (30.5%) of the 131 men who fulfilled the contemporary Epstein criteria for clinically insignificant prostate cancer before RP had pathologically unfavourable disease. Among our patients, no significant preoperative predictor of pathologically unfavourable disease was identified using uni- and multivariate analyses.
Our results showed that a significant proportion of contemporary Korean patients who meet all the conditions of the contemporary Epstein criteria for prediction of clinically insignificant prostate cancer might actually harbour prostate cancer with unfavourable pathological features. Such findings should be considered when treatment options are contemplated based upon the Epstein criteria among Asian patients.
探讨符合当代 Epstein 标准的临床意义不显著前列腺癌的韩国男性中经病理证实为不利前列腺癌的发生率。
这是一项回顾性研究,共纳入 131 名因临床意义不显著前列腺癌(根据当代 Epstein 标准定义)而行根治性前列腺切除术(RP)的韩国男性。我们评估了这些男性中不利前列腺癌(病理 Gleason 评分总和≥7 且/或存在前列腺外侵犯[EPE])的比例,并尝试使用单变量和多变量分析来确定此类不利肿瘤特征的有用预测因素。
在 131 名患有临床意义不显著前列腺癌的男性中,40 名(30.5%)在 RP 后出现病理 Gleason≥7 肿瘤。在这 40 名男性中,有 4 名(3.1%)在 RP 标本检查时还存在 EPE。所有 RP 标本检查未发现 Gleason 评分升级的患者均为器官局限性疾病。总体而言,在 RP 前符合当代 Epstein 标准的 131 名患有临床意义不显著前列腺癌的男性中,有 40 名(30.5%)存在病理上不利的疾病。在我们的患者中,单变量和多变量分析均未发现病理上不利疾病的显著术前预测因素。
我们的研究结果表明,符合当代 Epstein 标准预测临床意义不显著前列腺癌的韩国患者中,相当一部分实际上可能患有具有不利病理特征的前列腺癌。在亚洲患者中根据 Epstein 标准考虑治疗方案时,应考虑到这些发现。